Joung JY - Search Results

1

Establishment of Prospective Registry of Active Surveillance for Prostate Cancer: The Korean Urological Oncology Society Database.

Jung G, Kim JK, Jeon SS, Chung JH, Kwak C, Jeong CW, Ahn H, Joung JY, Kwon TG, Park SW, Byun SS. Jung G, et al. Among authors: joung jy. World J Mens Health. 2023 Jan;41(1):110-118. doi: 10.5534/wjmh.210163. Epub 2022 Feb 3. World J Mens Health. 2023. PMID: 35118841 Free PMC article.

2

Comparison of bone mineral loss by combined androgen block agonist versus GnRH in patients with prostate cancer: A 12 month-prospective observational study.

Kim SH, Joung JY, Kim S, Rha KH, Kim HG, Kwak C, Lee JY, Jeon SS, Hong SK, Jeong H, Jo MK, You D, Jeong IG, Hong JH, Kim CS. Kim SH, et al. Among authors: joung jy. Sci Rep. 2017 Mar 6;7:39562. doi: 10.1038/srep39562. Sci Rep. 2017. PMID: 28262724 Free PMC article.

3

Effect of renal embolization in patients with synchronous metastatic renal cell carcinoma: a retrospective comparison of cytoreductive nephrectomy and systemic medical therapy.

Kim SH, Kim JK, Park B, Joo J, Joung JY, Seo HK, Lee KH, Chung J. Kim SH, et al. Among authors: joung jy. Oncotarget. 2017 Jul 25;8(30):49615-49624. doi: 10.18632/oncotarget.17865. Oncotarget. 2017. PMID: 28548948 Free PMC article.

4

Survival outcomes of double- and triple-sequential targeted therapy in patients with metastatic renal cell carcinoma: a retrospective comparison.

Kim SH, Suh YS, Kim JK, Joung JY, Seo HK, Lee KH, Chung J. Kim SH, et al. Among authors: joung jy. Oncotarget. 2017 Oct 19;8(59):100056-100065. doi: 10.18632/oncotarget.21926. eCollection 2017 Nov 21. Oncotarget. 2017. PMID: 29245960 Free PMC article.

5

Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data.

Jeong CW, Kang M, Il Jung S, Kim TH, Park SW, Joung JY, Jeon SS, Hong JH, Lee JY, Chung BH, Ahn H, Kim CS, Kwon DD, Kwak C. Jeong CW, et al. Among authors: joung jy. Prostate Cancer Prostatic Dis. 2019 Mar;22(1):150-158. doi: 10.1038/s41391-018-0088-z. Epub 2018 Sep 13. Prostate Cancer Prostatic Dis. 2019. PMID: 30214035

6

Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy.

Kim SH, Kim JK, Park EY, Joo J, Lee KH, Seo HK, Joung JY, Chung J. Kim SH, et al. Among authors: joung jy. PLoS One. 2019 Feb 20;14(2):e0211105. doi: 10.1371/journal.pone.0211105. eCollection 2019. PLoS One. 2019. PMID: 30785902 Free PMC article.

7

Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting.

Jung SI, Kim MS, Jeong CW, Kwak C, Hong SK, Kang SH, Joung JY, Lee SH, Yun SJ, Kim TH, Park SW, Jeon SS, Kang M, Lee JY, Chung BH, Hong JH, Ahn H, Kim CS, Kwon DD. Jung SI, et al. Among authors: joung jy. Investig Clin Urol. 2020 Jan;61(1):19-27. doi: 10.4111/icu.2020.61.1.19. Epub 2019 Dec 10. Investig Clin Urol. 2020. PMID: 31942459 Free PMC article.

8

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients.

Kim SH, Kwon WA, Joung JY. Kim SH, et al. Among authors: joung jy. World J Mens Health. 2021 Apr;39(2):358-365. doi: 10.5534/wjmh.190135. Epub 2020 Feb 5. World J Mens Health. 2021. PMID: 32202082 Free PMC article.

9

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.

Shore ND, Saad F, Cookson MS, George DJ, Saltzstein DR, Tutrone R, Akaza H, Bossi A, van Veenhuyzen DF, Selby B, Fan X, Kang V, Walling J, Tombal B; HERO Study Investigators. Shore ND, et al. N Engl J Med. 2020 Jun 4;382(23):2187-2196. doi: 10.1056/NEJMoa2004325. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469183 Clinical Trial.

10

Cause of Mortality after Radical Prostatectomy and the Impact of Comorbidity in Men with Prostate Cancer: A Multi-institutional Study in Korea.

Pak S, You D, Jeong IG, Lee DE, Kim SH, Joung JY, Lee KH, Hong JH, Kim CS, Ahn H. Pak S, et al. Among authors: joung jy. Cancer Res Treat. 2020 Oct;52(4):1242-1250. doi: 10.4143/crt.2020.286. Epub 2020 Jul 3. Cancer Res Treat. 2020. PMID: 32632083 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page